Pseudomyogenic hemangioendothelioma of bone with rare WWTR1-FOSB fusion gene: Case report and literature review

Khaled A Murshed; Jorge Torres-Mora; Ahmed Mounir ElSayed; Adham Ammar; Issam Al-Bozom

doi:10.1002/ccr3.3808

Pseudomyogenic hemangioendothelioma of bone with rare WWTR1-FOSB fusion gene: Case report and literature review

Clin Case Rep. 2021 Jan 19;9(3):1494-1499. doi: 10.1002/ccr3.3808. eCollection 2021 Mar.

Authors

Khaled A Murshed¹, Jorge Torres-Mora², Ahmed Mounir ElSayed³, Adham Ammar¹, Issam Al-Bozom¹

Affiliations

¹ Department of Laboratory Medicine & Pathology Hamad Medical Corporation Doha Qatar.
² Mayo Clinic Laboratories- Rochester Main Campus Rochester MN USA.
³ Department of Orthopedics surgery Hamad Medical Corporation Doha Qatar.

Abstract

Pseudomyogenic hemangioendothelioma rarely arises in bone. WWTR1-FOSB fusion gene is rarely reported in PMHE of bone. Currently, fusion genes can be used as diagnostic markers in PMHE; however, their prognostic and therapeutic significance is unclear.

Keywords: FOSB; WWTR1; bone; pseudomyogenic hemangioendothelioma.

Publication types

Case Reports